Cancer cell heparanase activity associated with invasion and metastasis

Advances in Enzyme Regulation

Volumn 38, Issue 1, 1998, Pages 19-32

  Nicolson, Garth L ^a   Nakajima, Motowa ^b   Wakabayashi, Hironao ^a   Boyd, Douglas D ^c   Diaz, Dianna ^c   Irimura, Tatsuro ^d  

^a INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b NOVARTIS PHARMA K K   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ENZYME INHIBITOR; GLYCOSIDASE; HEPARANASE; HEPARIN;

ANIMAL; ANIMAL CELL; BLOOD; BREAST TUMOR; CANCER CELL; CANCER INVASION; CATTLE; CELL ADHESION; CELL CULTURE; CELL DIVISION; CONFERENCE PAPER; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; EXTRACELLULAR MATRIX; HUMAN; MELANOMA; METABOLISM; METASTASIS; MOUSE; NONHUMAN; RAT;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HEPARIN; HUMANS; MELANOMA; MICE; NEOPLASMS, EXPERIMENTAL; RATS; TUMOR CELLS, CULTURED;

ANIMALIA; BOS TAURUS;

EID: 0031851466     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0065-2571(97)00016-2     Document Type: Conference Paper

References (26)

1. S. PAGET, The distribution of secondary growths in cancer of the breast, Lancet 1, 571-573 (1889).
2. E. V. SUGARBAKER, Patterns of metastasis in human malignancies, Cancer Biol. Rev. 2, 235-278 (1982).
3. G. L. NICOLSON, Cancer metastasis: Tumor cell and host organ properties important in colonization of specific secondary sites, Biochim. Biophys. Acta 948, 175-224 (1988).
4. G. L. NICOLSON, Metastatic tumor cell interactions with endothelium, basement membrane and tissue, Curr. Opinion Cell Biol. 1, 1009-1019 (1989).
5. L. A. LIOTTA, C. N. RAO and U. M. WEWER, Biochemical interactions of tumor cells with the basement membrane, Ann. Rev. Biochem. 55, 1037-1057 (1986).
6. R. V. IZZO and A. D. MURDOCH, Proteoglycans of the extracellular environment: clues from the gene and protein side chains offer novel perspectives in molecular diversity and function, FASEB J. 10, 598-614 (1996).
7. M. NAKAJIMA, T. IRIMURA, N. DI FERRANTE and G. L. NICOLSON, Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endo-β-glucuronidase, J. Biol. Chem. 259, 2283-2290 (1984).
8. M. NAKAJIMA, T. IRIMURA, N. DI FERRANTE and G. L. NICOLSON, Heparan sulfate degradation correlates with tumor invasive and metastatic properties of B16 melanoma sublines, Science 220, 611-613 (1983).
9. M. NAKAJIMA, T. IRIMURA and G. L. NICOLSON, Tumor metastasis-associated heparanase (heparan sulfate β-endoglycosidase) in human melanoma cells, Cancer Lett. 31, 277-283 (1986).
10. M. NAKAJIMA, T. IRIMURA and G. L. NICOLSON, Heparanases and tumor metastasis, J. Cell Biochem. 36, 157-167 (1988).
11. L. JIN, M. NAKAJIMA and G. L. NICOLSON, Immunohistochemical localization of heparanase in mouse and human melanoma metastases, Int. J. Cancer 45, 1088-1095 (1990).
12. D. MARCHETTI, D. MENTER, L. JIN, M. NAKAJIMA and G. L. NICOLSON, Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production, Int. J. Cancer 55, 692-699 (1993).
13. D. MARCHETTI, D. MCQUILLAN, W. C. SPOHN, D. CARSON and G. L. NICOLSON, Neurotrophin stimulation of human melanoma cell invasion: Selected NT enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations, Cancer Res. 56, 2856-2863 (1996).
14. D. MARCHETTI and G. L. NICOLSON, Selected neurotrophin enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations, Advan. Enzyme Regul. 37, 111-134 (1997).
15. T. IRIMURA, M. NAKAJIMA and G. L. NICOLSON, Chemically modified heparins as inhibitors of heparan sulfate specific endo-β-glucoronidase (heparanase) of metastatic melanoma cells, Biochemistry 25, 5322-5328 (1986).
16. G. B. VILLANUEVA, M. NAKAJIMA and G. L. NICOLSON, Heparin derivatives as inhibitors of heparanase from metastatic melanoma cells, Ann. N.Y. Acad. Sci. 556, 496-498 (1989).
17. M. NAKAJIMA, A. S. DE CHAVIGNY, C. E. JOHNSON, J-. HAMADA, C. A. STEIN and G. L. NICOLSON, Suramin: A potent inhibitor of melanoma heparanase and invasion, J. Biol. Chem. 266, 9661-9666 (1991).
18. M. NAKAJIMA, T. IRIMURA and G. L. NICOLSON, A solid-phase substrate of heparan sulfate degrading endoglycosidase: Its application to assay of human melanoma for heparan sulfate degradative activity, Analyt. Biochem. 157, 162-171 (1986).
19. G. L. NICOLSON, K. DULSKI, C. BASSON and D. R. WELCH, Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties, Invasion Metastasis 5, 144-158 (1985).
20. G. L. NICOLSON, M. NAKAJIMA and T. IRIMURA, Invasion of vascular endothelium and organ tissue in vitro by B16 melanoma variants, pp. 275-297 in Mechanisms of Metastasis: Potential Therapeutic Implications, (K. V. HONN and B. SLOANE, eds.). Martinus Nijhoff, Boston, MA (1985).
21. P. HILGARD and R. D. THORNES, Anticoagulants in the treatment of cancer, Eur. J. Cancer 12, 755-762 (1976).
22. B. HAGMAR and K. NORRBY, Evidence for the effects of heparin on cell surfaces influencing experimental metastases, Int. J. Cancer 5, 72-81 (1970).
23. J. FOLKMAN, R. LANGER, R. J. LINHARDT, C. HAUDENSCHILD and S. TAYLOR, Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone, Science 221, 719-725 (1983).
24. G. L. NICOLSON, Metastatic tumor cell attachment and invasion assay utilizing vascular endothelial cell monolayers, J. Histochem. Cytochem. 30, 214-220 (1982).
25. r92,000 Progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma, Cancer Res. 53, 5802-5807 (1993).
26. R. J. PIETRAS, C. M. SZEGO, C. E. MANGAN, B. J. SEELER and M. M. BURTNETT, Elevated serum cathepsin B-1-like activity in women with neoplastic disease, Gynecol. Oncol. 7, 1-17 (1979).